Leap Therapeutics, Inc. - Current Ratio

The Current Ratio as of June 2026 (TTM) for Leap Therapeutics, Inc. (LPTX) is 27.28

According to Leap Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 27.28. This represents a change of 49.82% compared to the average of 18.21 of the last 4 quarters.

Leap Therapeutics, Inc. (LPTX) Historical Current Ratio (quarterly & annually)

How has LPTX Current Ratio performed in the past?

The mean historical Current Ratio of Leap Therapeutics, Inc. over the last ten years is 12.16. The current 27.28 Current Ratio has changed 22.34% with respect to the historical average. Over the past ten years (40 quarters), LPTX's Current Ratio was at its highest in in the June 2016 quarter at 44.40. The Current Ratio was at its lowest in in the September 2016 quarter at 0.

Leap Therapeutics, Inc. (LPTX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Leap Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Leap Therapeutics, Inc. (LPTX) Average Current Ratio

How has LPTX Current Ratio performed in the past?

The current Current Ratio of Leap Therapeutics, Inc. (LPTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Leap Therapeutics, Inc. (LPTX) Current Ratio vs. Peers

How is LPTX’s Current Ratio compared to its peers?

Leap Therapeutics, Inc.’s Current Ratio is greater than Citius Pharmaceuticals, Inc. (0.58), greater than Athira Pharma, Inc. (10.38), greater than Curis, Inc. (1.00), greater than Processa Pharmaceuticals, Inc. (0.98), greater than Apollomics, Inc. (0.96), greater than SeaStar Medical Holding Corporation (2.73), greater than BriaCell Therapeutics Corp. (7.07), greater than Aspire Biopharma Holdings, Inc. (2.26), greater than Entero Therapeutics, Inc. (0.16), greater than Daré Bioscience, Inc. (1.03),

Build a custom stock screener for Leap Therapeutics, Inc. (LPTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Leap Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Leap Therapeutics, Inc. (LPTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Leap Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.